3-Methylcrotonyl CoA Carboxylase 2 Deficiency
Oncology·MeSH: 3-methylcrotonyl CoA carboxylase 2 deficiency
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target 3-Methylcrotonyl CoA Carboxylase 2 Deficiency?
There are 1 clinical trial targeting 3-Methylcrotonyl CoA Carboxylase 2 Deficiency tracked by BioSniper.
What is the prevalence of 3-Methylcrotonyl CoA Carboxylase 2 Deficiency?
The estimated prevalence of 3-Methylcrotonyl CoA Carboxylase 2 Deficiency is approximately 5.0 per 100,000 population.
Deep-dive into 3-Methylcrotonyl CoA Carboxylase 2 Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis